RALTEGRAVIR PACKAGE INSERT PDF

Drug information on Raltegravir for patients and consumers. side effects of raltegravir, read the drug label or package insert or talk to your health care provider. Drug information on Raltegravir Tablet (chewable), tablet (film coated), granule for oral suspension for health care professionals. Drug Label Information. Updated February 7, If you are a See full prescribing information for ISENTRESS. ISENTRESS PATIENT PACKAGE INSERT.

Author: Akikasa Nikorr
Country: Brunei Darussalam
Language: English (Spanish)
Genre: Business
Published (Last): 11 December 2016
Pages: 113
PDF File Size: 6.62 Mb
ePub File Size: 10.10 Mb
ISBN: 451-2-13941-815-1
Downloads: 81154
Price: Free* [*Free Regsitration Required]
Uploader: Kazimi

Most commonly, these are “non-preferred” brand drugs or specialty prescription products. OR Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.

Isentress, Isentress HD (raltegravir) dosing, indications, interactions, adverse effects, and more

Must be swallowed whole Chewable tablet: Most commonly, these are “non-preferred” brand drugs. QL Quantity Limits Drugs that have quantity limits associated with each prescription.

Your list will be saved and can be edited at any time. Sign Up It’s Free!

No dose adjustment required Severe Child Pugh C: Combination regimen is based on safety, tolerability, pharmacokinetic parameters, and efficacy data through at least wk in a multicenter, open-label, noncomparative study in HIV-1 infected children and adolescents aged 4 wk to 18 yr.

Isentress, Isentress HD Classes: Use with caution if insdrt outweigh risks.

Tier Description 1 This drug is available at the lowest co-pay. By clicking send, you acknowledge that you have permission to email the recipient with this information. Most commonly, these are “preferred” on formulary brand drugs.

Raltegravir (MK, Isentress) –

This restriction requires that specific clinical criteria be met prior to the approval of the prescription. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed inserh risk.

Effect of food Low fat AUC ratio: Need a Curbside Consult? Postmarketing Reports Blood and lymphatic system disorders: Significant – Monitor Closely. Adding plans allows you to compare formulary status to other drugs in the same class. Individual plans may vary and formulary information changes.

Rhabdomyolysis Nervous system disorders: Chewable tablets contain phenylalanine, a component of aspartame Drug interactions overview Coadministration of raltegravir with drugs that inhibit UGT1A1 eg, rifampin may reduce plasma levels of raltegravir see Dosage Modifications Coadministration with other strong inducers eg, carbamazepine, raltdgravir, phenytoin of drug metabolizing enzymes on raltegravir is unknown and therefore not recommended.

Share Email Print Feedback Close. Do not use in pregnancy. This restriction typically requires that certain criteria be met prior to approval for the prescription. Print without Office Info. To view formulary information first create a list of plans. Oral Administration May administer with or without food Do not substitute chewable tablets or oral suspension for film-coated tablets; these are not bioequivalent, and therefore, are not interchangeable Film-coated tablet: What would you like to print?

Dosing Raltegeavir Combination regimen is based on safety, tolerability, pharmacokinetic parameters, and efficacy data through at least wk in a multicenter, open-label, noncomparative study in HIV-1 infected children and adolescents aged 4 wk to 18 yr Do not substitute chewable tablets or oral suspension for film-coated tablets; these are not bioequivalent, and therefore, are not interchangeable Do not switch between film-coated mg and mg tablet if prescribed dose is mg.

Positive isnert of human fetal risk. Coadministration with drugs that are strong inducers of UGT1A1 may result in reduced plasma concentrations of raltegravir. Most commonly, these are generic drugs. Print this section Print the entire contents of. Renal impairment No dosage adjustment required for any degree of renal impairment Dialysis: May be chewed or swallowed whole.

Access Denied

This drug is available at a middle level co-pay. Packagr explanations for tiers and restrictions. Not studied Isentress HD Safety and efficacy not established; administration is not recommended. Do not substitute chewable tablets or oral suspension for film-coated tablets; these are not bioequivalent, and therefore, are not interchangeable. Formulary Formulary Patient Discounts.

Animal studies show risk and human studies not available or neither animal nor human studies done. Available data from APR show no difference in rate of overall birth defects padkage raltegravir compared to background rate for major birth defects of 2. If you log out, you will be required to enter your username and password the next time you visit.